Information Journal Paper
APA:
CopyAshrafi Jigheh, Zahra, GHORBANI HAGHJO, AMIR, ARGANI, HASSAN, ROSHANGAR, LEILA, RASHTCHIZADEH, NADEREH, Sanajou, Davoud, Nazari Soltan Ahmad, Saeed, RASHEDI, JALIL, DASTMALCHI, SIAVOUSH, & MESGARI ABBASI, MEHRAN. (2019). Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(4), 384-390. SID. https://sid.ir/paper/734214/en
Vancouver:
CopyAshrafi Jigheh Zahra, GHORBANI HAGHJO AMIR, ARGANI HASSAN, ROSHANGAR LEILA, RASHTCHIZADEH NADEREH, Sanajou Davoud, Nazari Soltan Ahmad Saeed, RASHEDI JALIL, DASTMALCHI SIAVOUSH, MESGARI ABBASI MEHRAN. Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(4):384-390. Available from: https://sid.ir/paper/734214/en
IEEE:
CopyZahra Ashrafi Jigheh, AMIR GHORBANI HAGHJO, HASSAN ARGANI, LEILA ROSHANGAR, NADEREH RASHTCHIZADEH, Davoud Sanajou, Saeed Nazari Soltan Ahmad, JALIL RASHEDI, SIAVOUSH DASTMALCHI, and MEHRAN MESGARI ABBASI, “Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 4, pp. 384–390, 2019, [Online]. Available: https://sid.ir/paper/734214/en